Citadel Advisors’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.1K Sell
4,904
-2,650
-35% -$14.6K ﹤0.01% 5595
2025
Q1
$43.5K Buy
7,554
+997
+15% +$5.75K ﹤0.01% 5401
2024
Q4
$60.7K Buy
6,557
+1,894
+41% +$17.5K ﹤0.01% 5405
2024
Q3
$76.7K Sell
4,663
-19,425
-81% -$319K ﹤0.01% 5015
2024
Q2
$460K Buy
24,088
+3,632
+18% +$69.3K ﹤0.01% 3862
2024
Q1
$547K Sell
20,456
-10,865
-35% -$291K ﹤0.01% 3797
2023
Q4
$428K Sell
31,321
-5,230
-14% -$71.5K ﹤0.01% 3900
2023
Q3
$566K Buy
36,551
+3,779
+12% +$58.5K ﹤0.01% 3618
2023
Q2
$708K Sell
32,772
-7,215
-18% -$156K ﹤0.01% 3311
2023
Q1
$710K Sell
39,987
-3,527
-8% -$62.6K ﹤0.01% 3513
2022
Q4
$736K Buy
43,514
+4,006
+10% +$67.8K ﹤0.01% 3489
2022
Q3
$1.3M Buy
39,508
+6,727
+21% +$222K ﹤0.01% 3150
2022
Q2
$1.85M Buy
32,781
+282
+0.9% +$15.9K ﹤0.01% 2809
2022
Q1
$1.9M Sell
32,499
-304
-0.9% -$17.7K ﹤0.01% 3067
2021
Q4
$2.36M Sell
32,803
-257
-0.8% -$18.5K ﹤0.01% 2877
2021
Q3
$2.67M Sell
33,060
-26,242
-44% -$2.12M ﹤0.01% 2686
2021
Q2
$5.71M Sell
59,302
-29,066
-33% -$2.8M ﹤0.01% 1999
2021
Q1
$10.6M Sell
88,368
-1,119
-1% -$134K ﹤0.01% 1388
2020
Q4
$11.7M Sell
89,487
-268
-0.3% -$35.1K ﹤0.01% 1166
2020
Q3
$9.48M Buy
89,755
+85,192
+1,867% +$9M ﹤0.01% 1133
2020
Q2
$1.17M Sell
4,563
-2,397
-34% -$617K ﹤0.01% 2715
2020
Q1
$3.1M Sell
6,960
-59,516
-90% -$26.5M ﹤0.01% 1837
2019
Q4
$44.9M Sell
66,476
-11,987
-15% -$8.1M 0.02% 463
2019
Q3
$29M Sell
78,463
-12,686
-14% -$4.7M 0.01% 632
2019
Q2
$16.4M Buy
+91,149
New +$16.4M 0.01% 905